117 related articles for article (PubMed ID: 6117380)
21. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
[TBL] [Abstract][Full Text] [Related]
22. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
[TBL] [Abstract][Full Text] [Related]
23. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of prenalterol and dobutamine in a canine model of acute ischemic heart failure.
Kirlin PC; Pitt B; Lucchesi BR
J Cardiovasc Pharmacol; 1981; 3(4):896-905. PubMed ID: 6167819
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs.
Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
Clin Exp Pharmacol Physiol; 1983; 10(3):219-27. PubMed ID: 6627738
[TBL] [Abstract][Full Text] [Related]
28. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
Oltmanns D; Wester HA; Stein R
Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
[TBL] [Abstract][Full Text] [Related]
29. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
Tydén H; Johansson L; Nyström SO
Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
[TBL] [Abstract][Full Text] [Related]
30. Beta-adrenoceptor blocker intoxication: epidemiological data. Prenalterol as an alternative in the treatment of cardiac dysfunction.
Kulling P; Eleborg L; Persson H
Hum Toxicol; 1983 Apr; 2(2):175-81. PubMed ID: 6134663
[TBL] [Abstract][Full Text] [Related]
31. Prenalterol in cardiogenic shock following acute myocardial infarction.
Coma-Canella I; Lopez-Sendon J; Jadraque LM
Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
[TBL] [Abstract][Full Text] [Related]
32. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
Rönn O; Johnsson G; Lundborg P
J Cardiovasc Pharmacol; 1981; 3(3):477-84. PubMed ID: 6168829
[TBL] [Abstract][Full Text] [Related]
33. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
Drexler H; Löllgen H; Just H
Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
[No Abstract] [Full Text] [Related]
34. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Leinberger H; Mäurer W; Haueisen H; Schuler G; Kübler W
Acta Med Scand Suppl; 1982; 659():299-306. PubMed ID: 6127896
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic effects of intravenous metoprolol.
Bourdillon PD; Canepa-Anson R; Rickards AF
Am J Cardiol; 1979 Nov; 44(6):1195-200. PubMed ID: 495515
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
38. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
[TBL] [Abstract][Full Text] [Related]
39. Effect of prenalterol in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
[TBL] [Abstract][Full Text] [Related]
40. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
Doering W; Wauer B; Isbary J
Acta Med Scand Suppl; 1982; 659():307-14. PubMed ID: 6127897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
